IHS Chemical Week

Regions :: Western Europe

Lonza and Patheon Extend Exclusivity and Due Diligence Period

10:44 PM MDT | September 28, 2009 | Deepti Ramesh

Lonza says pharmaceutical contract manufacturing and development services company Patheon (Toronto), and Lonza have agreed to extend the exclusivity and due diligence period until October 15, 2009 to continue discussions regarding the previously announced non-binding proposal to acquire all of the outstanding restricted voting shares of Patheon at a price of $3.55/share. The offer price values Patheon at $460 million and gives Patheon an enterprise value of $700 million. The Lonza proposal does not commit either company to complete any transaction, and the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa